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ABSTRACT  
Objectives MEETINGDEM investigated whether the Dutch Meeting Centres Support 
Programme (MCSP) could be implemented in Italy, Poland and the UK with comparable 
benefits.  This paper reports on the impact on people living with dementia attending pilot 
Meeting Centres in the three countries. 
Methods Nine pilot Meeting Centres (MCs) participated (Italy-5, Poland-2, UK-2). 
Effectiveness of MCSP was compared to usual care (UC) on outcomes measuring behavioural 
and psychological symptoms (NPI), depression (CSDD) and quality of life (DQoL, QOL-AD), 
analysed by ANCOVAs in a 6 month pre-test/post-test controlled trial.  
Results Pre/post data were collected for 85 people with dementia and 93 carers (MCSP) and 74 
people with dementia /carer dyads’ receiving UC. MCSP showed significant positive effects for 
DQoL [Self-esteem (F=4.8, p=0.03); Positive Affect (F=14.93, p<0.00); Feelings of Belonging 
(F=7.77, p=0.01)] with medium and large effect sizes.  Higher attendance levels correlated with 
greater neuropsychiatric symptom reduction (rho=0.24, p=0.03) and a greater increase in feelings 
of support (rho=0.36, p=0.001).  
Conclusions MCSPs showed significant wellbeing and health benefits compared to UC, building 
on the evidence of effectiveness from the Netherlands. In addition to the previously reported 
successful implementation of MCSP in Italy, Poland and the UK, these findings suggest that 
further international dissemination of MCSP is recommended.  
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INTRODUCTION 
Many national dementia strategies recommend early diagnosis of dementia. Relatively few 
interventions  focus on supporting both the person diagnosed with dementia and their family 
carer, whereas evidence suggests that  combined interventions are more beneficial (Olazaran et 
al., 2010 Smits et al., 2007; Van ‘t Leven, 2013). The Meeting Centres Support Programme 
(MCSP) is a way of providing accessible support on a local level that focuses on both the person 
living with dementia and their family, providing accessible early support on a local level to meet 
the needs of people in the post-diagnostic stage. MCSP was developed, in collaboration with 
people with dementia and carers, following a community needs assessment in the Netherlands 25 
years ago (Dröes et al., 2004a,b). Typically MCSP serves a local community of around 5,000 
older people. The Meeting Centre (MC) “club” is offered 3 days per week, supporting 10-15 
people plus families per day in easily accessible community locations. Evidence-based post-
diagnostic psychosocial interventions are provided in a friendly manner, tailored to the needs of 
members. This is facilitated by a small team of staff and volunteers trained in the ethos of person 
centred dementia care, informed by the Adaptation-Coping Model (Dröes et al., 2010; Brooker et 
al., 2017). Family carers get practical information, advice, peer support, emotional support and 
social contact. The local focus fosters effective collaboration between care organisations, thus 
counteracting the fragmentation of care. 
In two Dutch multi-centre effect studies comparing people attending MCs with those attending 
regular day care, people utilising MCs displayed fewer behaviour problems, in particular less 
non-social behaviour and inactive behaviour, after seven months (Dröes et al., 2000, 2004a). 
Furthermore, there was a positive effect on depressive behaviour and self-esteem for people with 
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dementia and also benefits for family carers (Dröes et al., 2004b, 2006). Research in the 
Netherlands identified various factors that promoted successful implementation of MCSP 
(Meiland et al., 2004, 2005). An implementation guide, publications, films and a training course 
for staff assisted organisations to set up MCSPs supported by a national helpdesk. As a result 
MCSPs have spread across the country with more than 140 Meeting Centres in the Netherlands 
supporting 3,750 people and their carers annually. 
 
This paper reports on the JPND project MEETINGDEM (Dröes et al., 2017a) that aimed to 
transfer MCSP to Italy, Poland and the UK; to investigate whether adaptations were needed to 
support successful implementation in these countries and to evaluate if comparable benefits 
could be achieved. The adaptive implementation involved translating MCSP concepts and 
practicalities into a new country context. After exploring pathways to care (Szcześniak et al, in 
press), pilot Meeting Centres were successfully implemented in all countries in 2015 following a 
12-month period of collaborative community engagement and adaptation (Mangiaracina et al., 
2017). Within each participating country, a national project team conducted a standardised 
implementation study and assessed the impacts on people living with dementia and their family 
carers to ascertain if the results were comparable with those found in the Netherlands. 
Participants reported high levels of satisfaction with the support provided (Szcześniak et al., 
submitted). In this paper we focus on the impact of MCSP on social, behavioural and emotional 
functioning of people living with dementia. A separate paper details the impact on family carer 
outcomes measures (Evans et al., submitted). 
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METHOD 
Design 
As with the original Dutch study, a pre/post-test control group design was used comparing 
outcomes for people with dementia and family carers attending the MCSP with a Usual Care 
(UC) control group on several outcome measures. Measures were taken at pre-test and again 
after 6 months. Taking into account attrition of 15% over this period it was determined that 75 
persons with dementia/family carer dyads should be recruited to each arm (Total 150; 25 per arm 
in each of the 3 countries). This number was based on previous effect studies into MCSP, in 
which moderate to large effects were found, and a power calculation: to demonstrate moderate 
effects (d=0.5), with a power of 0.80 and alpha 0.05. Changes over time that may have impacted 
on the outcomes (illness, physical disability, significant medication changes and the use of other 
types of support) were monitored along with reasons for drop-out. The research underwent 
successful ethical review in the separate countries.   
Participants  
The main target group were people with mild to moderately severe dementia, living at home and 
having a carer. There were no exclusions on age or type of dementia.  
Meeting Centres Support Programme Intervention 
Pilot MCs were successfully provided in specific geographic local communities in all three 
countries during 2015-16. This included five MC’s in Italy (Lombardia and Emilia-Romagna 
regions), two in Poland (Wroclaw region) and two in the UK (Central England). It was not 
possible to explore the impact of all regions and jurisdictions within the countries. Materials and 
concepts developed in the Netherlands were translated. Compliance with the original MCSP 
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model was maintained to a high degree, although several country adaptations were made 
(Szcześniak et al., in press). The MC “club” was offered 3 days per week in the UK and Poland 
and 1.5 - 2 days per week in Italy. 10-15 dyads were supported per day. Participants for the 
MCSP group were recruited from people with dementia planning to attend the MC at least 1 day 
per week.  
 
Usual Care 
UC participants were recruited from a cohort group on a similar part of the dementia pathway 
within the same locality but outside the MC catchment area.   
 
Measures 
Background information on age, education level and gender was collected for all participants 
alongside information on individual factors (comorbidities, physical disability, psychotropic drug 
use, life events and use of services) that may have influenced outcomes. The Global 
Deterioration Scale [GDS] (Reisberg, 1987) was used to determine severity of dementia, the EQ-
5D (mobility) as an indication for physical disability. Three of the standardised measures which 
were utilised in the original Dutch effects study were used in the current study to assist with 
comparison. The DQoL (Brod et al., 1999) is a 30-item interview used with the persons with 
mild to moderate dementia to assess the impact on quality of life, consisting of five subscales 
showing good internal consistency and test–retest reliability. All subscales are scored so that a 
higher score indicates a better quality of life. The Cornell Scale for Depression in Dementia 
[CSDD] (Alexopoulos et al., 1988) is a 19-item rating scale for assessing symptoms of 
depression in persons with dementia, observed in the week prior to the assessment. The 
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Neuropsychiatric Inventory [NPI-Q] (Cummings et al., 1994, 1997; Kaufer et al, 2000) assesses 
dementia-related behavioural, mood and psychiatric symptoms alongside symptom severity and 
caregiver distress  The 13-item structured interview QOL-AD (Logsdon et al., 2002) was 
included as it suitable for people with more advanced dementia (Hoe et al., 2005). The Duke 
Social Support Inventory [DSSI] (George et al., 1989) was used to assess feelings of social 
support.  
Polish versions of the NPI-Q (Bidzan & Bidzan, 2005) and the GDS (Barcikowska, 2011) were 
used. Italian versions of the NPI-Q (Binetti et al, 1998) and the QOL-AD (Bianchetti et al, 2017) 
were used. An Italian version of the GDS was utilized. All Italian and Polish measures for which 
no translation was available were translated and adapted according to WHO formal criteria for 
questionnaires (WHO, 2017). Back translation of the Polish versions of the DQoL, CSDD, QOL-
AD and DSSI and back translations of the Italian versions of the DQoL, CSDD and DSSI were 
undertaken to ensure fidelity. 
 
Procedures 
A strong project management focus was employed throughout to ensure fidelity of the 
intervention to the original Dutch model and to maximise standardisation of research procedures 
across the different countries. All MCSP members were invited to participate in the research by 
the MC Manager within the first two weeks of attendance. Participation was entirely voluntary. 
For ethical and pragmatic reasons it was not possible to undertake baseline measures prior to MC 
attendance. The DQoL, QOL-AD and DSSI were administered by researchers during an 
interview with the person with dementia. The NPI-Q was completed by the family carers. The 
GDS and CSDD were completed by the MC Managers through interviews with the person with 
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dementia and the family carer. MC managers received training from the research team to do this. 
Participants who dropped out of the MC or UC before post-test data collection were not included 
in the effect evaluation. For the UC group, all measures were administered by researchers in 
participants’ own homes and the GDS and CSDD completed by a professional who knew the 
person. Follow-up data were collected using the same measures six months after the baseline 
data collection point. 
 
Data Analysis 
The aim of the analysis was to explore whether similar effects were found for these adaptively 
implemented Meeting Centres as had been found within the original Dutch effect study (Dröes et 
al., 2004). The current trial was exploratory in nature, being conducted during the cross country 
implementation study. Given the exploratory nature of the trial, and consequently the relatively 
small sample per country, a decision was made to run the same analyses as in the Netherlands 
and thus to do separate ANCOVA’s with a p-value of 0.05 and to not apply a Bonferroni 
correction on each test because of multiple testing. This enabled us to make more direct 
comparisons with the original Dutch research and to evaluate the feasibility of MCSP in other 
European countries. Following a similar process to that adopted in the Dutch study (Dröes et al., 
2004) the baseline characteristics of the participants in the MCSP and UC groups were analysed 
descriptively with differences between the groups being tested (two-sided, alpha 0.05) by t-tests 
(for ordinal and interval data that were normally distributed) and Chi2 tests (for nominal data). 
ANCOVA’s and t-tests were used on the outcome measures data that had normal distribution. t-
tests and Chi2 tests were undertaken to assess whether the MCSP intervention and UC control 
groups differed at baseline on characteristics such as gender, age and degree of dementia. 
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Characteristics that differed significantly between MCSP and UC at baseline and correlated with 
one or more outcome measure (potential confounding variables) were included as covariates in 
the analysis. The outcome measures data were analysed by covariance analyses (ANCOVAs) on 
the post-test measurements, while including baseline measurements as covariates. The data 
overall (all countries) were combined to assess differences between the MCSP and UC groups. 
Although the study was not sufficiently powered to fully test differences per country and 
between countries, we explored the differences between MCSP and UC groups at a country level 
(within the countries).  
 The ANCOVA analysis was conducted using the statistical package SPSS Version 23, where the 
options were selected to report the adjusted means and effect size in each case. Cohen’s d effect 
sizes (Cohen, 1988) were calculated for each ANCOVA. By using records of medication use, 
illness/significant life events in the weeks before the post test, and use of other support services, 
it was assessed as to whether these had influenced outcomes on a group basis. Spearman’s rank 
correlation between the outcome measures and attendance levels were calculated to further 
explore the effect of attendance on changes in outcomes for the MCSP group. 
 
RESULTS  
Numbers Recruited to Research: The numbers originally recruited, data collected at pre-test 
and post-test by country are shown in Figure 1. Between pre-test and post-test measures there 
was attrition of 27% in the MCSP group and 18% in the UC group. Those who dropped out 
tended to be slightly older and have more severe dementia. There were no significant 
characteristic differences in attrition between MCSP and UC groups. Data analysis was based on 
completed measures from 85 people with dementia attending the MC across Italy, Poland and the 
UK, and 74 people with dementia receiving UC.  
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Recruitment to the MCSP group was through the Meeting Centres in the respective countries. 
Recruitment to the UC group was through health or welfare organisations (UK 3/41; Italy 15/25; 
Poland 17/24) or through GP’s (UK 0/41; Italy 0/25; Poland 4/24) or through non-
governmental/charitable support services (UK 31/41; Italy 10/25; Poland 1/24) or other contacts 
(UK7/41; Italy 0/25; Poland 2/24).  
----- ---Insert FIGURE 1 about here ---------------------------------- 
 
Participant Characteristics: There were no significant differences between the participant 
characteristics (Table 1).  
----------------- Insert table 1 here ----------------------------- 
Comparison of outcome measures for MCSP and UC: ANCOVA’s were performed on all 
outcome measures overall and per country (Table 2). Severity of Dementia according to the 
GDS was included as an additional fixed factor within the analysis.  
----- ---Insert Table 2 about here ---------------------------------- 
Quality of Life: The ANCOVA results indicate that compared to the UC group, the MCSP group 
benefitted most on quality of life (DQoL). Significant differences were recorded on the domains 
self-esteem, positive affect and feelings of belonging, with medium to large effect sizes. There 
was a clear pattern within the DQoL scores either remaining stable or improving for the MCSP 
group over time whereas the pattern was much more mixed in the UC group. The ANCOVA did 
not show a statistically significant difference between the scores for the MCSP and UC groups 
on the QOL-AD.  
Depression: The ANCOVA did not show a significant difference between MCSP and UC for the 
CSDD.  
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Neuropsychiatric Symptoms: The ANCOVA did not show a significant difference between 
MCSP and UC at post-test. There were some differences in the changes in types of symptoms 
reported by the two groups (Table 3). Whilst these cannot be taken as evidence of effect of the 
intervention they are of interest in that they provide a picture of the prevalence of these 
symptoms in both groups and the change in 6 months. 
----- ---Insert Table 3 about here ---------------------------------- 
Feeling of Support:  No significant difference between MC and UC groups was found for any of 
the sub-domains of the DSSI.  
MC Attendance: How people utilised MCSP varied with some people utilising MCSP at every 
opportunity whereas others were infrequent users. The mean number of days’ attendance over 6-
months is shown in Table 4 overall and by countries. Secondary analysis using Spearman’s rank 
correlation between frequency of attendance and the changes in outcome measures demonstrated 
a significant correlation between higher attendance and more positive changes in symptom 
severity on the NPI (rho=0.24, p=0.03). There was also a significant correlation between higher 
attendance and a greater change in Duke SSI sub-domain of feelings of support (rho=0.36, 
p=0.001). 
---------------- insert table 4 here ----------------------- 
Country Differences: Italy had the highest attrition rate (36% between pre/post-test compared to 
21% in Poland and 17% in UK). The attrition in the original Dutch study was 21%. Participants 
in the UK MCSP and UC groups were more than twice as likely to be male (63% and 64% 
respectively) than in Italy and Poland where men only accounted for around 32% of study 
participants. The average age was similar across all countries (around 78 years).   
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The severity of dementia was quantified by GDS score, with the expectation that most 
participants (and thus all research participants) would be GDS stage 4-5. The reality was quite 
different and varied across countries (Table 5) with a substantial proportion of participants 
having relatively mild cognitive problems but also some with severe dementia. The UK had the 
widest spread of 11% showing very mild decline and 14% in the severe stages.  
----- ---Insert Table 5 about here ---------------------------------- 
On average, UK MCSP participants attended about half the number of days (mean = 34.7 days, 
SD 15.7) as their Polish counterparts (mean = 63.7 days, SD 18.7) and a third less than in Italy 
(mean = 48.1 days, SD 20.9) although individual variation was great in all countries. Country 
specific ANCOVAs (Table 2) showed a number of effects on Quality of life between the MCSP 
and UC groups in Italy, Poland and the UK:  Italy achieved large statistically significant effects 
on the DQoL sub-domains of Positive Affect (d=1.01) and overall Quality of Life (d=1.0), and a 
medium effect on Feelings of Belonging (d=0.57). They also achieved a statistically significant 
medium effect on the QOL-AD (d=0.74). In Poland the MCSP group rated their overall Quality 
of life at post-test as lower than the UC group (d=0.83), but compared to pre-test their quality of 
life did not change. In the UK the MCSP group showed more Positive Affect (d=0.68) at post-
test than the UC group (medium effect), and a large significant improvement on Negative Affect 
(d=0.99). The UK UC group rated their overall Quality of Life as better (d=1.04) than the MC 
group at post-test. The ANCOVAs did not show statistical significant effects on CSDD or NPI 
on a country level, but there were medium effect sizes for Italy regarding improvements in the 
CSDD and DSSI Satisfaction and Support. 
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A check on longitudinal changes in possible influencing factors (illness, psychotropic drugs etc ) 
between pre and post-test within and between groups, and life events within one month before 
the post test, did not reveal differences between groups that would have explained the effects 
found. 
DISCUSSION 
This research shows that it is possible to adaptively implement the Dutch MCSP model in three 
very different European countries and that the impact on people living with dementia is broadly 
comparable to earlier research (Dröes et al., 2000, 2004). As well as small to medium positive 
effects on Self-esteem the current study also found medium to large effects in Positive Affect 
and a medium effect on Feelings of Belonging. The effect on depressed behaviour was not 
replicated. The original Dutch research reported significant decreases in non-social and inactive 
behaviour in the MCSP group. In comparison with these findings the NPI data in the current 
study did not change significantly overall although there were some reductions reported for 
agitated and aggressive behaviour. Apathy increased in both groups but to a greater extent in the 
UC group. The significant correlation between higher number of attendances and a greater 
decrease in neuropsychiatric symptoms and greater feelings of support is of interest. A causal 
link cannot be attributed to this finding. It may be that those with increased severity of symptoms 
attended less, perhaps because their symptoms were disruptive or led to difficulties in them 
attending. Further study of this relationship may be useful in understanding the impact of 
attendance on neuropsychiatric symptom management.  
 
 Our study was primarily focused on the adaptive implementation and validation of the MCSP 
model. As a consequence, no detailed screening on type of dementia or cognitive impairments 
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was performed or taken into account in the analyses, although we corrected for between group 
differences in severity of dementia. In the current study, MCSP participants had more severe 
levels of dementia generally than the Dutch sample (Dröes et al.,2004). Also in the Dröes et al. 
(2004) study those in the UC group generally had more severe dementia than those in the MCSP 
group, whereas the opposite was true in the current study. Within the original Dutch research the 
UC group consisted of participants of Psychogeriatric Day Care units within Nursing homes. 
This may have impacted on fewer reports of apathy, inactivity and depressive symptoms in the 
UC group in the current study.   
Attendance patterns for MC’s were different across countries. Likewise, the usual care 
comparison was not the same in each country. There appeared to be an overall correlation 
between attendance to MCSP and neuropsychiatric symptoms and feelings of being supported. 
The question of whether higher levels of attendance might explain some of the differences in 
outcomes in the different countries is a possibility. It may also have been that positive outcomes 
may have been seen if the MC’s had just focussed on participants with more similar levels of 
dementia such as the GDS 4/5. The Meeting Centres were established over a relatively short 
period of time and it may have taken a greater amount of time for the model to bed into the new 
countries. All these issues may have diluted the effect. The study was not sufficiently powered to 
test this by within country analysis.  
This was an exploratory study of a complex intervention in three countries that required 
significant commitment from people to participate. The attrition rate of 27% in the MC group 
was quite high compared to other psycho-social interventions. In the original multicentre study in 
the Netherlands attrition was 20% between pre and post-test. This lower attrition might also be 
because the Dutch sample had less severe dementia.  
Meeting Centres Impacts on People Living with Dementia 
 
15 
 
The study had a number of limitations in evaluating the impact of the intervention on people 
living with dementia. Allocation to the intervention was not random. In order to recruit enough 
participants to the intervention group it was necessary to compare to a geographical control 
group where there was not a Meeting Centre. Assessors were not blind to the intervention that 
participants received. Baseline measurements took place up to one month after commencing at 
the MC. Only participants that completed six months of attendance were included in the 
analyses. The analysis also undertook numerous tests of significance and multiple comparisons. 
However, the current study was designed primarily as an implementation study where much of 
the time and energy was put in realising at least two Meeting Centres in each country who 
provided the full MCSP (Mangiaracina et al., 2017; Szcześniak et al, in press), were piloted and 
evaluated. Consequently larger samples with blind assessment were not possible in this study. 
For a thorough effect study per country separate larger sized RCT’s would be required.  
 
Despite these challenges, a successful intervention from one country into three others was 
replicated and found significant benefits. This study demonstrated that cross-country and 
multicentre evaluations of psychosocial interventions are feasible. Specifically this study 
suggests that the MCSP model can be successfully implemented in countries with very different 
health and social care systems. This should encourage other countries to implement this model 
with country specific adaptation. There was variance both within but also between countries in 
patterns of attendance in the different countries, which may have diluted the effect of the impact 
of the intervention on a group level and as a consequence decreased some of the overall benefits.   
The results of our study are in line with the literature on interventions supporting community 
dwelling people to live with dementia and to improve their social participation, thus aiming to 
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improve their social health and quality of life (Dröes et al., 2017b). Examples are: home 
community occupational therapy (Gitlin et al., 2003; Graff et al., 2007); the Enriched 
Opportunities Programme (Brooker et al., 2011); intergenerational programmes (Park, 2014); 
and easy access day treatment centres for people with dementia with carer support (Van Haeften-
Van Dijk et al., 2016). This current study is part of the emerging research into psychosocial 
interventions that report on positive outcomes rather than just reporting on the reduction of 
negative symptoms (Wolverson et al., 2016).  It also shows the strength of combining 
interventions for people living with dementia and caregivers to bring about clinically relevant 
improvements in well-being.   
 
CONCLUSION  
This study answered two main questions: Does the successful MCSP model developed in the 
Netherlands work in other European countries, more specifically in Italy, Poland and the UK, 
and are comparable benefits achieved for people with dementia and their carers in these 
countries?  The study showed this to be the case, the implementation proved successful in all 
three countries and the benefits were partially replicated. Further dissemination of MCSP is 
therefore recommended within the countries involved in the study, but also in other European 
countries and beyond. There is a great need for high quality implementation research to 
demonstrate how care interventions can be put into practice in a variety of settings and how 
evidence based practices can be effectively disseminated and transferred to other countries to 
share knowledge and improve dementia care on a European and world wide level. Demonstrating 
that outcomes of effective interventions in one country can be replicated in other countries is 
therefore very important.   
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KEY POINTS  
1. The Meeting Centres Support Programme (MCSP) was developed in the Netherlands 25 
years ago to provide local community support both to people living with dementia and 
their family carers. It has proven benefits and now supports nearly 4000 people per year 
across the Netherlands. 
2. Meeting Centres were successfully implemented in Italy, Poland and the UK utilising the 
Dutch model and adapting MCSP to country specific needs and contexts 
3. After 7 months attending the Meeting Centres people living with dementia reported 
significant improvements in self-esteem, positive affect and feelings of belonging. Higher 
levels of attendance were correlated with a greater reduction in distressing behaviour 
symptoms and greater feelings of support.  
4. The MCSP is transferable across different countries and shows benefits for people living 
with dementia at home. 
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Table 1 Data on persons with dementia using the Meeting Centres Support Programme 
(MCSP) and receiving Usual Care (UC) 
 MCSP 
group 
(n=85) 
UC group 
(n=74) 
Test 
statistic 
p (two-
sided) 
Sex  Male 36 (42.4%) 34 (45.9%) 
χ² = 0.21 0.65 
Female 49 (57.6%) 40 (54.1%) 
Age Mean age (Standard 
Deviation) 
Range 
78.4 (7.8) 
63-93 
78.5 (7.3) 
62-95 
t = 1.98 0.94 
<60 - - 
χ² = 4.20 0.12 
60-69 15 (18.1%) 7 (9.6%) 
70-79 27 (32.5%) 34 (46.6%) 
80+ 41 (49.4%) 32 (43.8%) 
Civil status Married/co-habiting/ civil 
partnership 
48 (56.5%) 48 (66.7%) 
χ² = 1.71 0.19 
Widowed/divorced/ 
single 
37 (43.5%) 24 (33.3%) 
Severity of 
dementia (GDS 
score) 
Mean Score (standard 
deviation)  
4.0 (1.1) 3.7 (1.1) t=1.98 0.11 
Median Score (Range) 4 (2-7) 4 (1-6)   
Primary care 
giver 
Spouse/partner 45 (52.9%) 43 (58.1%) 
χ² = 3.14 0.21 Daughter/son 30 (35.3%) 28 (37.8%) 
Other 10 (11.8%) 3 (4.1%) 
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Table 2: Outcome measures and results of ANCOVAs using pre-test and post-test means 
for Meeting Centre Support Programme (MCSP) and Usual Care (UC) groups.  
Measure (numbers in MCSP/UC) 
Pre-test Post-test Post-test 
ANCOVA 
adjusted 
MC/UC 
mean 
F P 
Effect 
size d 
MCSP 
mean 
(SD) 
UC 
mean 
(SD) 
MCSP 
mean 
(SD) 
UC 
mean 
(SD) 
D-QOL 
sub 
domains 
(range 
of 
scores) 
Sense of  
Aesthetics 
(5-25) 
Overall 
(n=82/69)  
18.3 
(3.6) 
17.7 
(5.1) 
19.4 
(3.8) 
18.6 
(5.2) 
18.8/18.3 0.56 0.46 0.13 
Italy 
(n=37/20) 
18.3 
(3.7) 
16.4 
(4.5) 
19.8 
(4.1) 
17.1 
(4.6) 
20.5/18.8 2.19 0.15 0.41 
Poland 
(n=19/18) 
18.1 
(3.3) 
18.3 
(4.5) 
19.0 
(3.1) 
18.6 
(3.6) 
19.1/18.5 0.35 0.56 0.20 
UK 
(n=26/31) 
18.6 
(4.0) 
18.3 
(5.8) 
19.1 
(4.0) 
19.6 
(6.3) 
18.5/18.6 0.03 0.87 0.06 
Self-esteem  
(4-20) 
Overall  
(n=78/65) 
13.5 
(3.4) 
13.4 
(2.8) 
14.3 
(3.1) 
13.1 
(3.7) 
14.2/13.1 4.80 0.03* 0.38 
Italy 
(n=35/20) 
14.5 
(3.3) 
13.0 
(2.3) 
15.4 
(2.8) 
13.3 
(2.6) 
15.4/13.8 3.76 0.06 0.55 
Poland 
(n=19/18) 
12.5 
(3.3) 
13.5 
(2.9) 
13.6 
(2.7) 
14.1 
(3.7) 
13.9/13.7 
0.07 
[0.17] 
0.80# 
[0.69] 
0.09  
0.14 
UK 
(n=24/27) 
12.9 
(3.3) 
13.7 
(3.1) 
13.1 
(3.3) 
12.4 
(4.3) 
13.4/11.8 2.39 0.13 0.45 
Positive 
affect 
(6-30) 
Overall 
(n=80/67)  
20.5 
(4.4) 
22.0 
(4.9) 
21.9 
(4.3) 
20.6 
(3.9) 
22.0/19.9 14.93 0.00* 0.65 
Italy 
(n=37/20) 
20.6 
(4.7) 
22.2 
(3.8) 
22.7 
(4.0) 
20.1 
(3.9) 
23.1/19.4 13.24 0.001* 1.01 
Poland 
(n=19/18) 
18.7 
(4.6) 
20.2 
(5.5) 
19.7 
(4.4) 
20.5 
(3.6) 
20.2/20.1 0.01 0.92 0.00 
UK 
(n=24/29) 
21.7 
(3.5) 
22.9 
(5.1) 
22.3 
(4.2) 
21.0 
(4.2) 
22.4/20.1 5.50 0.02* 0.68 
Negative 
affect (11-
55) 
Overall 
(n=79/67) 
27.5 
(8.0) 
27.1 
(8.2) 
26.3 
(7.6) 
25.2 
(8.5) 
25.8/25.0 1.00 0.32 0.17 
Italy 
(n=37/20) 
25.8 
(7.9) 
28.5 
(7.4) 
23.7 
(7.5) 
27.3 
(8.3) 
24.7/25.4 0.40 0.53 0.18 
Poland 
(n=19/18) 
31.4 
(7.4) 
30.9 
(7.1) 
27.8 
(6.9) 
28.5 
(6.8) 
27.6/28.6 0.52 0.48 0.26 
UK 
(n=23/29) 
27.2 
(8.0) 
23.8 
(8.4) 
29.3 
(7.0) 
21.8 
(8.7) 
27.2/21.9 11.57 0.001* 0.99 
Feelings of 
belonging 
(3-15) 
Overall 
(n=79/63) 
10.7 
(2.5) 
11.2 
(2.4) 
11.5 
(2.5) 
10.5 
(3.1) 
11.5/10.3 7.77 0.01* 0.48 
Italy 
(n=37/20) 
11.3 
(2.3) 
10.7 
(2.8) 
12.2 
(2.2) 
10.7 
(2.4) 
12.8/11.5 4.16 0.05* 0.57 
Poland 
(n=19/18) 
9.7 
(2.7) 
10.9 
(2.1) 
11.2 
(2.5) 
11.8 
(2.2) 
11.5/11.4 0.03 0.87 0.06 
UK 
(n=23/25) 
10.4 
(2.6) 
11.8 
(2.1) 
10.4 
(2.8) 
9.4 
(3.8) 
10.4/8.6 3.77 0.06 0.59 
Overall 
quality of 
life (1-5) 
Overall 
(n=81/69)  
3.3 
(0.8) 
3.6 
(1.0) 
3.3 
(0.8) 
3.6 
(1.0) 
3.1/3.4 
2.95 
[2.33] 
0.09# 
[0.13] 
0.29 
[0.26] 
Italy 
(n=36/20) 
3.5 
(0.9) 
3.4 
(1.1) 
3.5 
(0.8) 
2.8 
(0.6) 
3.4/2.6 12.74 0.001* 1.00 
Poland 
(n=19/18) 
3.1 
(0.4) 
3.8 
(1.0) 
3.1 
(0.4) 
3.6 
(0.8) 
3.1/3.6 
5.56 
[5.62] 
0.02*# 
[0.02*] 
0.82 
0.83 
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UK 
(n=26/31) 
3.3 
(0.9) 
3.6 
(1.1) 
3.2 
(0.9) 
4.2 
(1.0) 
3.1/3.9 14.04 0.00* 1.04 
QOL-AD (range 4-52) Overall  
(n=81/67) 
34.8 
(5.3) 
35.3 
(5.1) 
35.4 
(5.1) 
34.6 
(5.6) 
35.4/34.4 2.24 0.14 0.25 
Italy 
(n=37/19) 
34.4 
(5.5) 
32.6 
(4.2) 
35.0 
(5.0) 
30.5 
(5.8) 
35.2/31.7 6.91 0.01* 0.74 
Poland 
(n=19/18) 
34.3 
(5.2) 
37.6 
(4.2) 
36.3 
(5.0) 
38.1 
(4.4) 
37.5/37.1 0.12 0.74 0.13 
UK 
(n=25/30) 
35.8 
(5.2) 
35.7 
(5.5) 
35.3 
(5.3) 
35.2 
(4.3) 
34.8/34.6 0.04 0.85 0.06 
Cornell Scale 
Depression  
(range 0-38) 
Overall 
(n=80/63)  
8.3 
(5.6) 
6.3 
(4.7) 
7.8 
(5.6) 
6.8 
(6.1) 
6.9/7.3 0.30 0.58 0.09 
Italy 
(n=35/16) 
6.3 
(4.2) 
3.8 
(2.9) 
5.3 
(3.5) 
5.0 
(5.0) 
4.3/5.8 1.99 0.17 0.41 
Poland 
(n=19/18) 
10.2 
(6.1) 
7.6 
(4.8) 
9.4 
(6.2) 
9.8 
(5.5) 
8.5/10.5 1.71 0.20 0.45 
UK 
(n=26/29) 
9.5 
(6.3) 
6.9 
(5.1) 
10.2 
(6.3) 
5.9 
(6.6) 
8.8/6.4 2.93 0.09 0.48 
NPI 
Severity 
(range 0-36) 
Overall 
(n=91/72) 
9.5 
(5.6) 
7.8 
(5.7) 
9.4 
(5.6) 
8.3 
(6.1) 
8.9/8.9 0.001 0.98 0.00 
Italy 
(n=42/21) 
10.8 
(6.1) 
9.0 
(5.5) 
10.5 
(5.5) 
10.2 
(4.6) 
11.8/11.8 0.01 0.95 0.00 
Poland 
(n=21/19) 
7.2 
(3.7) 
8.0 
(5.5) 
6.3 
(4.6) 
7.8 
(6.1) 
5.3/6.6 0.63 0.43 0.27 
UK 
(n=28/32) 
9.4 
(5.7) 
6.8 
(5.9) 
10.1 
(5.8) 
7.3 
(6.8) 
8.7/7.9 0.40 0.53 0.17 
DUKe 
SSI 
Satisfaction  
(range 1-3)  
Overall 
(n=80/68) 
2.9 
(0.4) 
2.9 
(0.4) 
2.9 
(0.3) 
2.9 
(0.4) 
2.9/2.9 0.31 0.58 0.09 
Italy 
(n=37/20) 
2.8 
(0.4) 
2.8 
(0.4) 
3.0 
(0.2) 
2.7 
(0.6) 
3.0/2.8 
2.65 
[2.74] 
0.11# 
[0.10] 
0.45 
[0.46] 
Poland 
(n=19/18) 
2.8 
(0.4) 
3.0 
(0.0) 
2.8 
(0.5) 
3.0 
(0.0) 
2.9/2.9 0.33 0.57 0.20 
UK 
(n=24/30) 
2.9 
(0.3) 
2.8 
(0.5) 
3.0 
(0.2) 
2.9 
(0.4) 
2.9/2.9 0.06 0.81 0.06 
Help  
(range 0-
24)  
Overall 
(n=78/66) 
14.7 
(2.6) 
13.8 
(2.3) 
13.8 
(2.1) 
13.6 
(2.0) 
13.5/13.6 0.03 0.87 0.00 
Italy 
(n=34/20) 
15.6 
(2.6) 
14.1 
(3.1) 
14.3 
(1.7) 
14.0 
(2.1) 
13.8/13.8 0.003 0.96 0.00 
Poland 
(n=19/18) 
15.9 
(2.1) 
14.9 
(1.5) 
14.8 
(2.3) 
14.9 
(1.9) 
14.6/15.1 0.60 0.44 0.27 
UK 
(n=25/28) 
12.7 
(1.3) 
12.9 
(1.6) 
12.4 
(1.7) 
12.4 
(1.0) 
12.4/12.4 0.01 0.93 0.00 
Support  
(range 6-
18)  
Overall 
(n=82/68) 
15.0 
(2.8) 
14.9 
(2.7) 
15.7 
(2.8) 
15.2 
(2.6) 
15.7/15.1 
2.02 
[1.68] 
0.16# 
[0.20] 
0.24 
[0.21] 
Italy 
(n=37/20) 
15.2 
(2.7) 
14.8 
(2.5) 
16.7 
(2.0) 
15.2 
(2.4) 
17.0/15.8 3.08 0.09 0.45 
Poland 
(n=19/18) 
14.8 
(3.3) 
16.1 
(2.1) 
16.2 
(3.4) 
16.9 
(1.8) 
16.7/16.4 0.24 0.63 0.17 
UK 
(n=26/30) 
14.7 
(2.7) 
14.3 
(3.1) 
14.1 
(2.7) 
14.1 
(2.7) 
13.9/14.2 0.16 0.69 0.11 
* significant difference at 95%, p<0.05.  
# Levene’s test showed that the group variances were not equal, so an assumption of covariance analysis was 
violated[transformed using square root and ANCOVA repeated] 
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Table 3: Percentage of  Meeting Centres Support Programme (MCSP) and Usual Care 
(UC) group participants having symptoms on the NPI at pre-test and post-test 
 
NPI Item 
MCSP (n=93) UC  (n=74) 
Pre-test Post-test Pre-test  Post-test 
Apathy 68% 70% 57% 66% 
Depression/dysphoria 62% 63% 50% 46% 
Anxiety 63% 63% 62% 62% 
Eating problems 56% 47% 26% 23% 
Agitation/aggression 47% 40% 36% 51% 
Irritability/liability 53% 53% 45% 45% 
Delusions 37% 32% 28% 24% 
Aberrant motor behaviour 38% 34% 28% 32% 
Sleeping disturbances 43% 50% 40% 34% 
Hallucinations 20% 28% 20% 27% 
Euphoria 13% 12% 11% 11% 
Disinhibition 25% 31% 27% 30% 
 
 
 
 
 
 
Table 4. Attendances for research participants over 6 months from pre-test to post-test by 
country and overall.   
 N Mean SD Min Max 
Italy      
Person with dementia - days attended MC 39 48.1  20.9 5 79 
Carer hours of attendance 39 18.2 hours  19.8 1 74 
Poland      
Person with dementia - days attended MC 20 63.7  18.7 3 83 
Carer hours of attendance 20 19.4 hours 47.3 0.5 218.3 
UK      
Person with dementia - days attended MC 28 34.7  15.7 11 63 
Carer hours of attendance 22 65 hours 52.3 2 211.7 
ALL COUNTRIES       
Person with dementia - days attended MC 87 47.4  21.5 3 83 
Carer hours of attendance 81 31.2 hours 43.2 0.5 218.3 
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TABLE 5: Stage of dementia for Meeting Centres Support Programme and Usual Care 
participants by country at pre-test   
GDS Stage 
(Reisberg) 
All Countries Italy Poland UK 
 MCSP 
(n=84) 
UC 
(n=69) 
MCSP 
(n=38) 
UC 
(n=20) 
MCSP 
(n=19) 
UC 
(n=18) 
MCSP 
(n=27) 
UC 
(n=31) 
Stage 1-2: No 
or Very Mild 
Cognitive 
Decline 
7  
(8.3%) 
13 
(18.8%) 
2  
(5.3%) 
- 
2 
 (10.5%) 
4  
(22.2%) 
3  
(11.1%) 
9  
(29.0%) 
Stage 3: Mild 
Cognitive 
Decline 
21 
(25.0%) 
9 
(13.0%) 
13 
(34.2%) 
1  
(5.0%) 
6 
 (31.6%) 
4  
(22.2%) 
2  
(7.4%) 
4  
(12.9%) 
Stage 4: 
Moderate 
Cognitive 
Decline 
27 
(32.1%) 
33 
(47.8%) 
16 
(42.1%) 
12 
(60.0%) 
6  
(31.6%) 
7  
(38.9%) 
5  
(18.5%) 
14 
(45.2%) 
Stage 5: 
Moderately 
Severe 
Cognitive 
Decline 
24 
(28.6%) 
11 
(15.9%) 
6  
(15.8%) 
6  
(30.0%) 
5  
(26.3%) 
3  
(16.7%) 
13 
(48.1%) 
2  
(6.45%) 
Stage 6: Severe 
Cognitive 
Decline 
(Middle 
Dementia) 
4  
(4.8%) 
3  
(4.4%) 
1  
(2.6%) 
1  
(5.0%) 
- - 
3  
(11.1%) 
2  
(6.45%) 
Stage 7: Very 
Severe 
Cognitive 
Decline (Late 
Dementia) 
1  
(1.2%) 
- - - 
- - 
1  
(3.7%) 
- 
 
 
